About the Journal

INSTITUTO MÁRIO PENNA - Núcleo de Ensino, Pesquisa e Inovação (NEPI)

A reference in oncology in the state of Minas Gerais, the Mário Penna Institute is projecting itself as a leading player on the scientific scene through the Mário Pena Institute - Teaching, Research and Innovation. The unit aims to expand academic projects, transform health care and foster cancer diagnostic innovation in the country.

The Education sector promotes numerous events and activities that contribute to the continuous training of its clinical and care staff, as well as the dissemination of relevant content on the diagnosis and treatment of cancer pathologies, receiving the support of numerous care and teaching institutions and industries in the sector.

With regard to Clinical Research, the sector works in partnership with the pharmaceutical industry to validate new therapeutic modalities, bringing hope of treatment to patients who often have no alternatives. The Translational Research sector has an exquisite technological park and works to develop innovative and strategic research, generating knowledge and advances that contribute to the diagnosis, monitoring and treatment of cancer.

The Mário Penna Journal - molecular and clinical cancer research is the journal linked to the Mário Penna Institute - Teaching, Research and Innovation. It is an important tool for disseminating knowledge in the field of oncology and human health.

Its mission is to promote multidisciplinary scientific dissemination in the field of clinical, translational and basic research in oncology, involving researchers, doctors and other health professionals in oncology research.

The aim is to encourage the scientific production of scientific articles, reviews and case studies related to the various themes related to oncology specialties and their interrelationships, such as: Clinical Oncology, Hematology, Oncopediatrics, Oncological Surgery, Oncological Nursing, Oncological Pharmacy, Clinical Research and Translational Research in Oncology.

The target audience is undergraduates, postgraduates, masters, doctors, professors, researchers and the scientific community in general.

ISSN: 2965-159X

 

 

Announcements

Nova edição da Revista MPJ já está no ar!

2025-10-23

Temos o prazer de anunciar que a nova edição da Revista Mario Penna Journal (MPJ) acaba de ser publicada! 

Esta edição reúne artigos científicos com temas atuais e relevantes na área de Oncologia, trazendo contribuições significativas para a pesquisa, o ensino e a prática clínica.

Acesse e confira: https://revista.mariopenna.org.br/mpj/issue/view/5

Atenciosamente

Letícia da Conceição Braga – PhD

Editora da Revista MPJ

Coordenadora do Laboratório de Pesquisa Básica e Translacional em Oncologia

Instituto Mário Penna - Núcleo de Ensino, Pesquisa e Inovação

revistampj@mariopenna.org.br

www.mariopenna.org.br

http://lattes.cnpq.br/9979493696239511

https://www.linkedin.com/in/leticia-braga-12170627/

https://orcid.org/0000-0002-6181-9410

Read more about Nova edição da Revista MPJ já está no ar!

Current Issue

Vol. 2 No. 2 (2024): Mário Penna Journal
View Vol. 2 No. 2 (2024): Mário Penna Journal
Published: 2025-10-23

Full Issue

Artigos

  • Editorial

    Letícia da Conceição Braga
    10-12
    DOI: https://doi.org/10.61229/mpj.v2i2.67

  • INFECTIVE ENDOCARDITIS IN A ONCOLOGY PATIENT: Treatment with Tricuspid Valve Replacement Using a Porcine Xenograft INFECTIVE ENDOCARDITIS IN A ONCOLOGY PATIENT: Treatment with Tricuspid Valve Replacement Using a Porcine Xenograft

    Milena Pereira Santos, Giancarlo Grossi Mota, Demétrius Lúcius Sales Costa, Eduardo Augusto Resende Penido, Clara Pereira Santos
    13-20
    DOI: https://doi.org/10.61229/mpj.v2i2.44

  • BCG-REFRACTORY NON-MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER: Case Report relato de caso

    Mariza Corrêa Petrini, Ellias Magalhães e Abreu Lima
    22-27
    DOI: https://doi.org/10.61229/mpj.v2i2.45

  • Evaluation of the OvarianTag biomarker panel's applicability in detecting Krukenberg tumors.

    Ana Beatriz Ramos Do Nascimento, Eduardha Santos Temponi Barroso, Anna Carolina Almeida de Paula, Stephanie Braga Gonçalves da Silva, Rafaela L opes Figueiredo de Andrade, Thalía Rodrigues de Souza Zózimo, Aline Luiza Costa e Silva, Ramon De Alencar Pereira, Pedro Henrique Villar Delfino, Paulo Guilherme de Oliveira Salles, Jorge Gomes Goulart Ferreira
    29-40
    DOI: https://doi.org/10.61229/mpj.v2i2.58

  • TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER WITH PEMBROLIZUMAB: AN INTEGRATIVE REVIEW UMA REVISÃO INTEGRATIVA

    Aline Ferreira, Eduarda Cabral, Alessandra Cristina Pupin Silvério
    42-52
    DOI: https://doi.org/10.61229/mpj.v2i2.65

  • Identification of Genetic Variants Associated With Triple-Negative Breast Cancer And High-Grade Serous Ovarian Cancer

    Arthur Schenider Oliveira Felipe, Maria Vitória Costa Felipe, Álvaro Percínio Costa, Diogo Gomes da Costa, Fábio Ribeiro Queiroz, Letícia da Conceição Braga
    54-56
    DOI: https://doi.org/10.61229/mpj.v2i2.46

  • BENIGN BRENNER TUMOR ASSOCIATED WITH MUCINOUS CYSTOADENOMA: CASE SERIES SÉRIE DE CASOS

    Eduardha Santos Temponi Barroso, Raíssa Êmily Andrade Souza , Paula Pereira de Souza, Priscila Rosse Lopes Viana, Vitória Bese Moreira , Aline Luiza Costa e Silva , Jorge Gomes Goulart Ferreira, Eduardo Batista Cândido
    57-60
    DOI: https://doi.org/10.61229/mpj.v2i2.60

  • EXTRACELLULAR VESICLE MIRNAS PROFILE AS PREDICTORS OF PATHOLOGICAL COMPLETE RESPONSE IN BREAST CANCER UNDERGOING NEOADJUVANT THERAPY

    Álvaro Percínio Costa, Angelo Borges de Melo Neto, Paulo Guilherme de Oliveira Salles, Agnaldo Lopes da Silva Filho, Laurence Rodrigues do Amaral, Fábio Ribeiro Queiroz
    61-64
    DOI: https://doi.org/10.61229/mpj.v2i2.61

  • Análise dos níveis de citocinas no líquido ascítico derivado de tumores ovarianos para identificação de potenciais biomarcadores diagnósticos e prognósticos da doença

    Marcela Rosa
    65-68
    DOI: https://doi.org/10.61229/mpj.v2i2.59

  • EVALUATION OF PLASMA CYTOKINE PROFILE AS PROGNOSTIC BIOMARKERS FOR COLORECTAL CANCER

    Sarah Cristina Ferreira Guimaraes, Jorge Gomes Goulart Ferreira, Marcela Maria de Oliveira Rosa, Anna Carolina Almeida Paula, Danilo Roberto Carvalho Ferreira, Estefânia Mara do Nascimento Martins, Bruna de Paula Dias, Paulo Guilherme de Oliveira Salles, Clascidia Aparecida Furtado
    69-72
    DOI: https://doi.org/10.61229/mpj.v2i2.64

  • VALIDAÇÃO DE DADOS IN SILICO DE BIOMARCADORES IMUNOLÓGICOS E ALVOS DE IMUNOTERAPIA NO GLIOBLASTOMA IDH- WILDTYPE PELA IMUNO-HISTOQUÍMICA

    Matheus Bortolini Lima Muniz, Karla Cândida Parreira, Leonardo Augusto Wendling Henriques, Paulo Guilherme de Oliveira Salles, Izabela Ferreira Gontijo de Amorim, Francisco Augusto Silva Mesquita, Ramon de Alencar Pereira
    73-76
    DOI: https://doi.org/10.61229/mpj.v2i2.49

  • Identificação de variantes em genes da Via MAPK em uma coorte de pacientes com Câncer de Mama

    Kassyane Furtado, Thalia Rodrigues de Souza Zózimo, Rafaela Lopes Figueiredo de Andrade de Andrade, Carolina Pereira de Souza Melo, Vasco Ariston de Carvalho Azevedo, Paulo Guilherme de Oliveira Salles
    85-87
    DOI: https://doi.org/10.61229/mpj.v2i2.54

  • Long non-coding RNAs associated with progression and response to treatment in cervical cancer

    Bruna Custódio Dias Duarte, Angelo Borges de Melo Neto, Álvaro Percínio Costa, Carolina Pereira de Souza Melo, Paulo Guilherme de Oliveira Salles, Agnaldo Lopes da Silva Filho, Wander de Jesus Jeremias, Pedro Luiz Lima Bertarini, Laurence Rodrigues do Amaral, Matheus de Souza Gomes, Fábio Ribeiro Queiroz
    77-80
    DOI: https://doi.org/10.61229/mpj.v2i2.62

  • ANALYSIS OF miRNAS IN EXTRACELLULAR VESICLES FROM OVARIAN CANCER PATIENTS: identification of potential biomarkers for diagnosis and prognosis

    Diogo Gomes da Costa, Angelo Borges de Melo Neto, Paulo Guilherme de Oliveira Salles, Letícia da Conceição Braga, Adriana Abalen Martins Dias, Fábio Ribeiro Queiroz
    81-84
    DOI: https://doi.org/10.61229/mpj.v2i2.50

  • IMMUNOHISTOCHEMICAL ANALYSIS OF PATIENTS WITH LUMINAL B BREAST CANCER: PATHOLOGICAL PARAMETERS AND THERAPEUTIC STRATEGIES

    Maria Vitória Costa Felipe, Arthur Schenider Oliveira Felipe, Ramon de Alencar Pereira, Diogo Diogo Gomes da Costa, Jorge Jorge Gomes Goulart Ferreira, Fábio Ribeiro Queiroz
    88-91
    DOI: https://doi.org/10.61229/mpj.v2i2.53

  • ANALYSIS OF THE EXTRACELLULAR MATRIX AS A POTENTIAL PROGNOSTIC INDICATOR IN PATIENTS WITH IDH - WILD TYPE GLIOBLASTOMA

    Karla Parreira, Matheus Bortolini Lima Muniz, Leonardo Augusto Wendling Henriques, Paulo Guilherme de Oliveira Salles, Izabela Ferreira Gontijo de Amorim , Ramon de Alencar Pereira
    92-95
    DOI: https://doi.org/10.61229/mpj.v2i2.52

  • RELATIONSHIP OF VIMENTIN EXPRESSION WITH CHEMOTHERAPY RESISTANCE IN PATIENTS WITH HIGH-GRADE SEROUS OVARIAN CANCER

    Francisco Augusto Silva Mesquita, Laura Kaori Menegussi Nakano, Izabela Ferreira Gontijo, Paulo Guilherme de Oliveira Salles, Ramon de Alencar Pereira
    96-98
    DOI: https://doi.org/10.61229/mpj.v2i2.51

  • Vimentin Expression as an Indicator of Aggressiveness in Molecular Subtypes of Breast Cancer: Immunohistochemical and Survival Analysis

    Laura Kaori, Francisco Augusto Silva Mesquita, Ramon de Alencar Pereira, Paulo Guilherme de Oliveira Salles, Ana Luiza de Magalhães Freitas, Izabela Ferreira Gontijo de Amorim
    99-102
    DOI: https://doi.org/10.61229/mpj.v2i2.56
View All Issues